Quad commits to 1 billion vaccines via India's Biological E facility by year-end

It reaffirms the Quad's commitment to supporting a free and open Indo-Pacific and outlines progress in areas such as vaccine production, maritime security, and counter-terrorism.

Who it concerns: The statement involves the governments of Australia, India, Japan, and the United States. It affects or names ASEAN (specifically Cambodia as 2022 Chair), Tonga, Myanmar, North Korea, and regional partners in the Indo-Pacific. Sectors and groups mentioned include healthcare workers, vaccine manufacturers (Biological E Ltd), maritime agencies, and strategic thinkers.

What was agreed

• Quad partners have collectively provided more than 500 million vaccine doses and pledged to donate more than 1.3 billion doses globally.
• Expansion of vaccine production at the Biological E Ltd facility in India aims to deliver at least 1 billion vaccines by the end of 2022.
• First batch of Quad-supported vaccines expected in the first half of 2022.
• Australia proposed to host an Indo-Pacific Clean Energy Supply Chain Forum in mid-2022.
• Japan will host the next Quad Leaders’ Summit in the first half of 2022.
• Commitment to support ASEAN’s Outlook on the Indo-Pacific and Cambodia’s role as 2022 ASEAN Chair.

Also in the document

• Specific commitment to deliver at least 1 billion vaccines by the end of 2022 via the Biological E Ltd facility in India.
• Proposal for an Indo-Pacific Clean Energy Supply Chain Forum to be hosted by Australia in mid-2022.
• Condemnation of terrorist attacks in India, specifically the 26/11 Mumbai and Pathankot attacks.
• Call for the implementation of ASEAN’s Five-Point Consensus regarding the crisis in Myanmar.